AI assistant
Sending…
DAVITA INC. — Director's Dealing 2016
Dec 2, 2016
30643_dirs_2016-12-01_b830405f-9ee3-416a-a867-4f4037b4a1dc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA INC. (DVA)
CIK: 0000927066
Period of Report: 2016-11-30
Reporting Person: Rodriguez Javier (CEO-Kidney Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-30 | Common Stock | M | 80000 | $36.96 | Acquired | 144264 | Direct |
| 2016-11-30 | Common Stock | F | 46447 | $63.66 | Disposed | 97817 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-30 | Stock Appreciation Rights | $36.96 | M | 80000 | Disposed | 2016-12-08 | Common Stock (80000) | Direct |
Footnotes
F1: The Stock Appreciation Rights were granted on 12/8/2011, and vested in three equal installments on 12/8/2013, 12/8/2014 and 12/8/2015, respectively.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25